014950 — Samik Pharm Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩142bn
- KR₩124bn
- KR₩56bn
Annual cashflow statement for Samik Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | 2,969 | 3,522 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | 229 | 1,408 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -2,228 | -1,897 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Change in Taxes Payable | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | 2,248 | 4,385 |
| Capital Expenditures | -1,377 | -848 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | -491 | -1,313 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -1,868 | -2,161 |
| Financing Cash Flow Items | -141 | -282 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | -250 | 253 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 131 | 2,477 |